Correlation Between Assembly Biosciences and Inhibikase Therapeutics
Can any of the company-specific risk be diversified away by investing in both Assembly Biosciences and Inhibikase Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Assembly Biosciences and Inhibikase Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Assembly Biosciences and Inhibikase Therapeutics, you can compare the effects of market volatilities on Assembly Biosciences and Inhibikase Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Assembly Biosciences with a short position of Inhibikase Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Assembly Biosciences and Inhibikase Therapeutics.
Diversification Opportunities for Assembly Biosciences and Inhibikase Therapeutics
0.14 | Correlation Coefficient |
Average diversification
The 3 months correlation between Assembly and Inhibikase is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Assembly Biosciences and Inhibikase Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibikase Therapeutics and Assembly Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Assembly Biosciences are associated (or correlated) with Inhibikase Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibikase Therapeutics has no effect on the direction of Assembly Biosciences i.e., Assembly Biosciences and Inhibikase Therapeutics go up and down completely randomly.
Pair Corralation between Assembly Biosciences and Inhibikase Therapeutics
Given the investment horizon of 90 days Assembly Biosciences is expected to under-perform the Inhibikase Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Assembly Biosciences is 1.61 times less risky than Inhibikase Therapeutics. The stock trades about -0.02 of its potential returns per unit of risk. The Inhibikase Therapeutics is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest 138.00 in Inhibikase Therapeutics on August 28, 2024 and sell it today you would earn a total of 96.00 from holding Inhibikase Therapeutics or generate 69.57% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Assembly Biosciences vs. Inhibikase Therapeutics
Performance |
| Timeline |
| Assembly Biosciences |
| Inhibikase Therapeutics |
Assembly Biosciences and Inhibikase Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Assembly Biosciences and Inhibikase Therapeutics
The main advantage of trading using opposite Assembly Biosciences and Inhibikase Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Assembly Biosciences position performs unexpectedly, Inhibikase Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibikase Therapeutics will offset losses from the drop in Inhibikase Therapeutics' long position.| Assembly Biosciences vs. Eliem Therapeutics | Assembly Biosciences vs. Scpharmaceuticals | Assembly Biosciences vs. Milestone Pharmaceuticals | Assembly Biosciences vs. Seres Therapeutics |
| Inhibikase Therapeutics vs. DiaMedica Therapeutics | Inhibikase Therapeutics vs. Milestone Pharmaceuticals | Inhibikase Therapeutics vs. Seres Therapeutics | Inhibikase Therapeutics vs. Oncolytics Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |